12:00 AM
 | 
Dec 06, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

AB Therapeutics preclinical data

In mouse models of NSCLC, ABTL0812 and ABTL1014 each reduced tumor growth by 70% vs. both placebo...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >